DK0589488T3 - I det væsentlige optisk rent (-)-cimaterol og dens syreadditionssalte samt dens anvendelse som lægemiddel eller vækstfremmer - Google Patents

I det væsentlige optisk rent (-)-cimaterol og dens syreadditionssalte samt dens anvendelse som lægemiddel eller vækstfremmer

Info

Publication number
DK0589488T3
DK0589488T3 DK93117935.2T DK93117935T DK0589488T3 DK 0589488 T3 DK0589488 T3 DK 0589488T3 DK 93117935 T DK93117935 T DK 93117935T DK 0589488 T3 DK0589488 T3 DK 0589488T3
Authority
DK
Denmark
Prior art keywords
cimaterol
drug
well
acid addition
addition salts
Prior art date
Application number
DK93117935.2T
Other languages
Danish (da)
English (en)
Inventor
Wolfgang Dr Dipl-Chem Resemann
Adolf Duerr
Guenther Prof Dr Engelhardt
John Francis Dr Quirke
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Application granted granted Critical
Publication of DK0589488T3 publication Critical patent/DK0589488T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pain & Pain Management (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
DK93117935.2T 1990-05-04 1991-04-26 I det væsentlige optisk rent (-)-cimaterol og dens syreadditionssalte samt dens anvendelse som lægemiddel eller vækstfremmer DK0589488T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014252A DE4014252A1 (de) 1990-05-04 1990-05-04 Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Publications (1)

Publication Number Publication Date
DK0589488T3 true DK0589488T3 (da) 1998-05-04

Family

ID=6405664

Family Applications (2)

Application Number Title Priority Date Filing Date
DK91106774.2T DK0455155T3 (da) 1990-05-04 1991-04-26 Adskillelse af enantiomere af cimaterol
DK93117935.2T DK0589488T3 (da) 1990-05-04 1991-04-26 I det væsentlige optisk rent (-)-cimaterol og dens syreadditionssalte samt dens anvendelse som lægemiddel eller vækstfremmer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK91106774.2T DK0455155T3 (da) 1990-05-04 1991-04-26 Adskillelse af enantiomere af cimaterol

Country Status (27)

Country Link
US (4) US5248695A (enExample)
EP (2) EP0589488B1 (enExample)
JP (1) JP2944777B2 (enExample)
KR (1) KR0183024B1 (enExample)
AR (1) AR247728A1 (enExample)
AT (2) ATE158277T1 (enExample)
AU (1) AU645313B2 (enExample)
BG (1) BG60743B1 (enExample)
CA (1) CA2041818C (enExample)
CZ (1) CZ286389B6 (enExample)
DE (3) DE4014252A1 (enExample)
DK (2) DK0455155T3 (enExample)
ES (2) ES2109412T3 (enExample)
FI (1) FI109600B (enExample)
GR (2) GR3017064T3 (enExample)
HU (1) HU214335B (enExample)
ID (1) ID966B (enExample)
IE (2) IE80651B1 (enExample)
IL (1) IL98030A (enExample)
NO (1) NO174803B (enExample)
NZ (1) NZ238032A (enExample)
PT (1) PT97544B (enExample)
RU (1) RU2002737C1 (enExample)
SG (1) SG45439A1 (enExample)
SK (1) SK279258B6 (enExample)
TW (1) TW197415B (enExample)
ZA (1) ZA913337B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
EP0892639A4 (en) * 1996-01-29 1999-06-09 Savor Evelyn PROCESS FOR THE TREATMENT OF UNWANTED UTERINE CONTRACTIONS USING OPTICALLY PURE R OR RR ISOMERS OF AGONIST -g (b) -2 ADRENERGIC AGONISTS
EP1787529A3 (en) * 1997-04-30 2009-11-18 Courage Corporation Pty Ltd. Composition and methods using an eutomer
BR9815470A (pt) 1997-04-30 2001-10-23 Bridge Pharma Inc Composição e processo usando um eutÈmero
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
RU2201420C2 (ru) * 1998-11-03 2003-03-27 Новартис Аг Нитрилы дипептидов
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
NZ522677A (en) * 2000-04-27 2004-10-29 Boehringer Ingelheim Pharma Novel, slow-acting betamimetics, a method for their production and their use as medicaments
US20030162459A1 (en) * 2002-02-27 2003-08-28 Osbon Robert Lindsay Method for producing a nonwoven fabric with enhanced characteristics
WO2004103057A2 (en) * 2003-05-15 2004-12-02 The University Of Georgia Research Foundation, Inc. Compositions and methods for inducing adipose tissue cell death
ATE380027T1 (de) 2003-09-09 2007-12-15 Fumapharm Ag Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
SG124283A1 (en) * 2004-03-24 2006-08-30 Trusted Hub Ltd Document signature method & system
MX2007012794A (es) * 2005-04-13 2008-02-22 Astion Pharma As Composiciones para el tratamiento de trastornos del tejido conectivo de la piel.
US20090181369A1 (en) * 2005-05-27 2009-07-16 George Q Daley Methods for the Treatment of Disease
US20090305225A1 (en) * 2005-06-13 2009-12-10 Galbraith Richard A Inhibition of Creatine Uptake to Promote Weight Loss
RU2408014C2 (ru) * 2009-03-10 2010-12-27 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет им. Н.И. Пирогова Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования преждевременных родов инфекционного генеза
BR112015011897B1 (pt) 2012-12-03 2021-11-03 Pfizer Inc Compostos moduladores seletivos do receptor de andrógeno e seu uso

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136601C (enExample) * 1967-06-15
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4814350A (en) * 1986-09-10 1989-03-21 American Cyanamid Company Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
ES2075255T3 (es) 1995-10-01
TW197415B (enExample) 1993-01-01
EP0589488A1 (de) 1994-03-30
NO174803B (no) 1994-04-05
DE4014252A1 (de) 1991-11-07
NZ238032A (en) 1996-02-27
GR3025547T3 (en) 1998-03-31
CA2041818C (en) 2003-02-11
IL98030A0 (en) 1992-06-21
FI912151L (fi) 1991-11-05
HUT60999A (en) 1992-11-30
CA2041818A1 (en) 1991-11-05
KR910019966A (ko) 1991-12-19
CS129291A3 (en) 1991-11-12
FI109600B (fi) 2002-09-13
AU645313B2 (en) 1994-01-13
FI912151A0 (fi) 1991-05-03
IL98030A (en) 1995-12-31
ZA913337B (en) 1993-01-27
JP2944777B2 (ja) 1999-09-06
DE59105957D1 (de) 1995-08-17
PT97544B (pt) 1998-08-31
EP0455155B1 (de) 1995-07-12
JPH04225944A (ja) 1992-08-14
AU7611191A (en) 1991-11-07
US5248695A (en) 1993-09-28
ATE124932T1 (de) 1995-07-15
IE911507A1 (en) 1991-11-06
GR3017064T3 (en) 1995-11-30
HU214335B (hu) 1998-03-02
SK279258B6 (sk) 1998-08-05
DE59108853D1 (de) 1997-10-23
IE69017B1 (en) 1996-07-24
NO911746D0 (no) 1991-05-03
BG60743B1 (bg) 1996-02-29
SG45439A1 (en) 1998-01-16
US5648386A (en) 1997-07-15
AR247728A1 (es) 1995-03-31
CZ286389B6 (cs) 2000-03-15
EP0589488B1 (de) 1997-09-17
ES2109412T3 (es) 1998-01-16
HU911502D0 (en) 1991-11-28
PT97544A (pt) 1992-01-31
IE80651B1 (en) 1998-11-04
US5292753A (en) 1994-03-08
ID966B (id) 1996-09-30
DK0455155T3 (da) 1995-11-13
EP0455155A1 (de) 1991-11-06
BG94342A (en) 1994-06-30
ATE158277T1 (de) 1997-10-15
US5395957A (en) 1995-03-07
NO911746L (no) 1991-11-05
KR0183024B1 (ko) 1999-05-15
NO174803C (enExample) 1994-07-13
RU2002737C1 (ru) 1993-11-15

Similar Documents

Publication Publication Date Title
DK0589488T3 (da) I det væsentlige optisk rent (-)-cimaterol og dens syreadditionssalte samt dens anvendelse som lægemiddel eller vækstfremmer
DE10075006I1 (de) Verwendung von (s)(+)-2-aethoxy-4- N- 1-(2piperidino-phenyl)-3-methyl-1-butyl aminocarbonylmethyl-Benzoesaeure zur Herstellung eines Langzeitantidiabetikums
NO179911C (no) Optisk aktivt 5H-pyrrolo[3,4-bÅpyrazinderivat samt farmasöytiske preparater inneholdende derivatet
DK248084A (da) Cyclohexandioncarboxylsyrederivater samt deres fremstilling og anvendelse som herbicider og/eller plantevaekstregulatorer
FI904230A7 (fi) Akryylihappojohdannaisia
DK414189A (da) Aminosyreforbindelse og dens anvendelse
FI950377L (fi) Pyridinyylimetyylisulfinyyli-1H-bentsimidatsoliyhdisteiden optisesti puhtaat suolat
FI97887B (fi) 5,5-bis(perfluorialkyyliheterometyyli)-2-hydroksi-2-okso-1,3,2-dioksafosforinaanit, niiden asykliset fosforihapokejohdannaiset sekä suolat tai esterit
FI890689A7 (fi) 3-alkenyyli-1-atsabisyklo/3.2.0/hept-2-eeni-2-karboksyylihappoyhdisteet
DK190885D0 (da) 2-(n-substitueret guanidino)-4-heteroarylthiazolderivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutisk praeparat indeholdende forbindelserne
DK349387D0 (da) Nitrofuranderivater samt fremgangsmaade til fremstilling deraf og anvendelse af forbindelserne som laegemiddel
DK159848C (da) 7-hydroxy-1,2,3,4,4a,5,6,10b-oktahydrobenzo(f)-quinoliner eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende saadanne forbindelser
DK0627161T3 (da) Anvendelse af L-carnitin og alkanoyl L-carnitiner til opbevaring af blod til trandfusioner og stabiliserende opløsninger in
DK112287A (da) Anvendelse af 2-alkoxy-n-(1-azabicyclo-oe2,2,2aaoct-3-yl)-benzamider og -thiobenzamider samt farmaceutisk acceptable syreadditionssalte deraf som laegemidler
DK307186A (da) (r)-2-(4-(5-chlor-3-fluorpyridin-2-yloxy)-phenoxy)-propionsyrepropinylester samt dens fremstilling og anvendelse som herbicid og plantevaeksthaemmende middel
DE3674351D1 (de) Optisch aktive benzoesaeureesterderivate.
DK395687A (da) Leukocyt-elastase-inhibitor og dens anvendelse som laegemiddel
DK300583A (da) Racemiske eller optisk aktive eburnanoximderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
FI883782L (fi) Menetelmä titaanidioksidipigmentin valmistamiseksi
FI910394A7 (fi) Substituoituja B-pyrimidinyylioksi(tio)-ja B-triatsinyylioksi(tio)sykloalkyylikarboksyylihappojohdannaisia, menetelmä niiden valmistamiseksija niiden käyttö aineina, joilla on herbisidinen, fungisidinen ja kasvien kasvua säätelevä vaikutus
DK179986D0 (da) Racemiske og optisk aktive 1,12b-disubstituerede octahydroindolo(2,3-a)quinolizinderivater eller cis- og trans-isomere eller syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika, mellemprodukter ved fremstillingen og disses fremstilling
DK384785A (da) Optisk aktive, substituerede 1,4-dihydropyridiner eller syreadditionssalte deraf, deres fremstilling og anvendelse som calciumantagonister
DE68921230D1 (de) Optisch-aktive Pyridylethanol-Derivate.
NO970697L (no) Substituerte tiofenalkenylkarboksylsyreguanidider, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsene
DK180086D0 (da) 12b-substituerede 1-hydroxymethyl-octahydroindolo(2,3-a)-quinolizinderivater eller isomere eller syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika